Long-term clinical experience with pure bicarbonate peritoneal dialysis solutions

被引:2
作者
Montenegro, J [1 ]
Saracho, RM [1 ]
Martínez, IM [1 ]
Muñoz, RI [1 ]
Ocharan, JJ [1 ]
Valladares, E [1 ]
机构
[1] Hosp Galdakao, Serv Nephrol, E-48960 Galdakao, Vizcaya, Spain
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2006年 / 26卷 / 01期
关键词
acid-base status; bicarbonate; dialysis adequacy; residual renal function; ultrafiltration;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The aim of this prospective study was to collect long-term experience in incident peritoneal dialysis (PD) patients treated with pure bicarbonate-buffered PD fluids. Methods: The metabolic parameters acidosis, acid-base status, adequacy, fluid balance, nutritional markers, calcium, phosphorus, parathyroid hormone (PTH), and general laboratory work and medication were compared between incident PD patients in two groups: one treated with a 34 mmol/L bicarbonate-buffered PD fluid (BIC), the other with a 35 mmol/L lactate-buffered PD fluid (LAC). The observation period included 5 visits from 1 month (visit 1) until 12 months (visit 5) after the start of dialysis treatment. For the descriptive analysis, means and standard deviations were calculated. Student's t-test and Linear mixed models were used to compare the two treatment groups. Results: 36 patients were followed for 12 months, 18 in the BIC group and 18 in the LAC group. Statistically significant differences between the groups (at the end of study) were found. In BIC group, venous plasma bicarbonate was 27.4 +/- 2.3 mmoL/L, base excess 0.8 +/- 2.2 mmol/L, and pH 7.31 +/- 0.05; in LAC group, venous bicarbonate was 25.9 +/- 2.4 mmol/L, base excess -0.6 +/- 2.1 mmoL/L, and pH 7.30 +/- 0.04. No patient from the BIC group needed oral bicarbonate,in contrast to 4 patients in the LAC group. Whereas peritoneal urea and creatinine clearances did not differ between the groups, there was better renal solute clearance in the BIC group, accompanied by better-preserved diuresis at 12 months (1333 +/- 935 mL with BIC vs 839 +/- 556 mL with LAC). The reverse was true for ultrafiltration. Conclusions: Pure bicarbonate-buffered PD solutions were superior in correcting metabolic acidosis and they allowed omission of oral bicarbonate. The minor ultrafiltration with bicarbonate-buffered PD solutions was counterbalanced by better-preserved residual renal function with these solutions.
引用
收藏
页码:89 / 94
页数:6
相关论文
共 19 条
  • [1] Caravaca F, 2002, PERITON DIALYSIS INT, V22, P414
  • [2] Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis
    Chung, SH
    Heimbürger, O
    Stenvinkel, P
    Bergström, J
    Lindholm, B
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (11) : 2240 - 2245
  • [3] A controlled trial of two bicarbonate-containing dialysis fluids for CAPD -: Final report
    Coles, GA
    O'Donoghue, DJ
    Pritchard, N
    Ogg, CS
    Jani, FM
    Gokal, R
    Cancarini, GC
    Maiorca, R
    Tranæus, A
    De Vos, C
    Hopwood, A
    Faict, D
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (12) : 3165 - 3171
  • [4] Randomized long-term evaluation of bicarbonate-buffered CAPD solution
    Feriani, M
    Kirchgessner, J
    La Greca, G
    Passlick-Deetjen, J
    [J]. KIDNEY INTERNATIONAL, 1998, 54 (05) : 1731 - 1738
  • [5] FERIANI M, 1997, PERITON DIAL INT S2, V17, P51
  • [6] Predictors of the rate of decline of residual renal function in incident dialysis patients
    Jansen, MAM
    Hart, AAM
    Korevaar, JC
    Dekker, FW
    Boeschoten, EW
    Krediet, RT
    [J]. KIDNEY INTERNATIONAL, 2002, 62 (03) : 1046 - 1053
  • [7] Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels
    Jones, S
    Holmes, CJ
    Krediet, RT
    Mackenzie, R
    Faict, D
    Tranaeus, A
    Williams, JD
    Coles, GA
    Topley, N
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (04) : 1529 - 1538
  • [8] Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis
    Medcalf, JF
    Harris, KPG
    Walls, J
    [J]. KIDNEY INTERNATIONAL, 2001, 59 (03) : 1128 - 1133
  • [9] Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556
  • [10] Advanced glycation end products: A nephrologist's perspective
    Raj, DSC
    Choudhury, D
    Welbourne, TC
    Levi, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (03) : 365 - 380